Clinical Trials Exploring Bevacizumab in NSCLC

Publication
Video
Special ReportsNSCLC (Issue 11)
Volume 4
Issue 2

Catherine Shu, MD, medical oncologist, Division of Hematology/Oncology, Columbia University Medical Center, discusses two clinical trials exploring the use of bevacizumab (Avastin) in patients with non-small cell lung cancer.

Related Videos
Related Content